Vividion Therapeutics, Inc.

Organization

San Diego, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical compositions comprising WRN helicase inhibitors
- Patent number 12,187,685
- Issue date Jan 7, 2025
- Vividion Therapeutics, Inc.
- Shota Kikuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cereblon modulators and uses thereof
- Patent number 11,771,689
- Issue date Oct 3, 2023
- VIVIDION THERAPEUTICS, INC.
- Benjamin F. Cravatt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cereblon modulators and uses thereof
- Patent number 10,869,860
- Issue date Dec 22, 2020
- VIVIDION THERAPEUTICS, INC.
- Benjamin F. Cravatt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
In vivo engineered cereblon protein
- Patent number 10,781,239
- Issue date Sep 22, 2020
- VIVIDION THERAPEUTICS, INC.
- David Weinstein
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE FORM OF (R)-1-(3-(3-(4-AMINOPYRIMIDIN-2-YL)-5-CHLOROPHE...
- Publication number 20250228866
- Publication date Jul 17, 2025
- Vividion Therapeutics, Inc.
- Wei LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
- Publication number 20250188040
- Publication date Jun 12, 2025
- Vividion Therapeutics, Inc.
- Shota Kikuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING STAT3
- Publication number 20250059161
- Publication date Feb 20, 2025
- Vividion Therapeutics, Inc.
- Qingfeng WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K
- Publication number 20250026721
- Publication date Jan 23, 2025
- Vividion Therapeutics, Inc.
- Junko TAMIYA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KEAP1 INHIBITORS AND USES THEREOF
- Publication number 20250011291
- Publication date Jan 9, 2025
- Vividion Therapeutics, Inc.
- Karl BEDKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS SELECTIVE FOR JAK1 AND METHODS OF USE
- Publication number 20240270705
- Publication date Aug 15, 2024
- Vividion Therapeutics, Inc.
- Benjamin HORNING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORS AND USES THEREOF
- Publication number 20240226114
- Publication date Jul 11, 2024
- Vividion Therapeutics, Inc.
- David WEINSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
- Publication number 20240140915
- Publication date May 2, 2024
- Vividion Therapeutics, Inc.
- Shota Kikuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING IMMUNE-RELATED PROTEINS
- Publication number 20240123078
- Publication date Apr 18, 2024
- Vividion Therapeutics, Inc.
- Matthew PATRICELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
- Publication number 20240067612
- Publication date Feb 29, 2024
- Vividion Therapeutics, Inc.
- Shota Kikuchi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED ISOINDOLINONES AS MODULATORS OF CEREBLON-MEDIATED NEO-S...
- Publication number 20230045737
- Publication date Feb 9, 2023
- Vividion Therapeutics, Inc.
- Robert HUBBARD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IN VIVO ENGINEERED CEREBLON PROTEIN
- Publication number 20220298213
- Publication date Sep 22, 2022
- Vividion Therapeutics, Inc.
- David WEINSTEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CEREBLON MODULATORS AND USES THEREOF
- Publication number 20220062248
- Publication date Mar 3, 2022
- Vividion Therapeutics, Inc.
- Benjamin F. CRAVATT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IN VIVO ENGINEERED CEREBLON PROTEIN
- Publication number 20210002337
- Publication date Jan 7, 2021
- Vividion Therapeutics, Inc.
- David WEINSTEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS OF MODULATING PROTEIN DEGRADATION
- Publication number 20200239530
- Publication date Jul 30, 2020
- Vividion Therapeutics, Inc.
- Matthew PATRICELLI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IN VIVO ENGINEERED CEREBLON PROTEIN
- Publication number 20200216507
- Publication date Jul 9, 2020
- Vividion Therapeutics, Inc.
- David WEINSTEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CEREBLON MODULATORS AND USES THEREOF
- Publication number 20200206201
- Publication date Jul 2, 2020
- Vividion Therapeutics, Inc.
- Benjamin F. CRAVATT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
98853803 - VIVIDION THERAPEUTICS
- Serial number 98853803
- Filing date Nov 14, 2024
- Vividion Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98853814
- Serial number 98853814
- Filing date Nov 14, 2024
- Vividion Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90780754 - VIVIDION THERAPEUTICS
- Serial number 90780754
- Registration number 6774098
- Filing date Jun 17, 2021
- Vividion Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto

Vividion Therapeutics, Inc.

Organization

Patents Grantslast 30 patents

Pharmaceutical compositions comprising WRN helicase inhibitors

Cereblon modulators and uses thereof

Cereblon modulators and uses thereof

In vivo engineered cereblon protein

Patents Applicationslast 30 patents

CRYSTALLINE FORM OF (R)-1-(3-(3-(4-AMINOPYRIMIDIN-2-YL)-5-CHLOROPHE...

PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS

COMPOUNDS AND METHODS FOR MODULATING STAT3

COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K

KEAP1 INHIBITORS AND USES THEREOF

COMPOUNDS SELECTIVE FOR JAK1 AND METHODS OF USE

INHIBITORS AND USES THEREOF

PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS

COMPOUNDS AND METHODS FOR MODULATING IMMUNE-RELATED PROTEINS

PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS

SUBSTITUTED ISOINDOLINONES AS MODULATORS OF CEREBLON-MEDIATED NEO-S...

IN VIVO ENGINEERED CEREBLON PROTEIN

CEREBLON MODULATORS AND USES THEREOF

IN VIVO ENGINEERED CEREBLON PROTEIN

COMPOUNDS AND METHODS OF MODULATING PROTEIN DEGRADATION

IN VIVO ENGINEERED CEREBLON PROTEIN

CEREBLON MODULATORS AND USES THEREOF

Trademarklast 30 trademarks

98853803 - VIVIDION THERAPEUTICS

98853814

90780754 - VIVIDION THERAPEUTICS